Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Vincent

Showing results (291-300 of 987) with videos related to

Pageof 99
Sort By:
Critical Care (London, England)|June 4, 2020
Precision medicine for COVID-19: a call for better clinical trialsGentle Sunder Shrestha, Hem Raj Paneru, Jean-Louis Vincent
Anesthesia and Analgesia|May 17, 2019
Hypertonic Saline in Human Sepsis: A Systematic Review of Randomized Controlled TrialsDiego Orbegozo, Jean-Louis Vincent, Jacques Creteur, et al.
BMC Medicine|January 7, 2012
suPAR as a prognostic biomarker in sepsisKatia Donadello, Sabino Scolletta, Cecilia Covajes, et al.
Critical Care Medicine|October 24, 2009
Improving clinical trials in the critically illDerek C Angus, Jean-Paul Mira, Jean-Louis Vincent
Critical Care Medicine|September 29, 2007
Beneficial effects of recombinant human activated protein C in a ewe model of septic shockZhen Wang, Fuhong Su, Peter Rogiers, et al.
Pulmonary Pharmacology & Therapeutics|December 8, 2006
The effects of dopamine on the respiratory system: friend or foe?Agnieszka Ciarka, Jean-Louis Vincent, Philippe van de Borne
The Journal of Infection|April 16, 2008
A prospective evaluation of the Infection Probability Score (IPS) in the intensive care unitAlvise Martini, Leonardo Gottin, Christian Mélot, et al.
JAMA|February 20, 2014
Short-acting β-blocker administration in patients with septic shockDiego Orbegozo Cortés, Fabio Silvio Taccone, Jean-Louis Vincent
Critical Care (London, England)|July 18, 2016
qSOFA does not replace SIRS in the definition of sepsisJean-Louis Vincent, Greg S Martin, Mitchell M Levy
Intensive Care Medicine|September 18, 2010
High rate ultrafiltration in anasarca: 33 l of net negative fluid balance in 52 h!Luc Kugener, Alexandre Brasseur, David Fagnoul, et al.
Pageof 99

Showing results (291-300 of 987) with videos related to

Sort By:
Pageof 99
Critical Care (London, England)|June 4, 2020
Precision medicine for COVID-19: a call for better clinical trialsGentle Sunder Shrestha, Hem Raj Paneru, Jean-Louis Vincent
Anesthesia and Analgesia|May 17, 2019
Hypertonic Saline in Human Sepsis: A Systematic Review of Randomized Controlled TrialsDiego Orbegozo, Jean-Louis Vincent, Jacques Creteur, et al.
BMC Medicine|January 7, 2012
suPAR as a prognostic biomarker in sepsisKatia Donadello, Sabino Scolletta, Cecilia Covajes, et al.
Critical Care Medicine|October 24, 2009
Improving clinical trials in the critically illDerek C Angus, Jean-Paul Mira, Jean-Louis Vincent
Critical Care Medicine|September 29, 2007
Beneficial effects of recombinant human activated protein C in a ewe model of septic shockZhen Wang, Fuhong Su, Peter Rogiers, et al.
Pulmonary Pharmacology & Therapeutics|December 8, 2006
The effects of dopamine on the respiratory system: friend or foe?Agnieszka Ciarka, Jean-Louis Vincent, Philippe van de Borne
The Journal of Infection|April 16, 2008
A prospective evaluation of the Infection Probability Score (IPS) in the intensive care unitAlvise Martini, Leonardo Gottin, Christian Mélot, et al.
JAMA|February 20, 2014
Short-acting β-blocker administration in patients with septic shockDiego Orbegozo Cortés, Fabio Silvio Taccone, Jean-Louis Vincent
Critical Care (London, England)|July 18, 2016
qSOFA does not replace SIRS in the definition of sepsisJean-Louis Vincent, Greg S Martin, Mitchell M Levy
Intensive Care Medicine|September 18, 2010
High rate ultrafiltration in anasarca: 33 l of net negative fluid balance in 52 h!Luc Kugener, Alexandre Brasseur, David Fagnoul, et al.
Pageof 99